Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Cash flows from operating activities:
Net Loss	$ (21,950)	$ (310,674)
Adjustments to reconcile net loss to cash used in operating activities:
Depreciation	627	1,797
Amortization	12,120	11,879
Changes in operating assets and liabilities
(Increase) decrease in accounts receivable	(16,075)	5,468
Increase in inventory	(12,945)	(4,832)
Decrease in other current assets	2,569	875
(Decrease) increase in accounts payable	(5,440)	101,272
Decrease in accounts payable, related parties	(8,464)	(5,084)
Increase in accrued royalties	805	540
Increase in accrued payroll		25,655
Increase in notes payable, related parties		10,000
Increase in notes payable, related parties, convertible		20,000
Increase in contract liability	8,315
Increase in other current liabilities	42,350	59,925
Net cash provided (used) in operating activities	1,912	(83,179)
Net cash used in investing activities
Cash flows from financing activities:
Proceeds from sale of common stock		50,000
Proceeds from issuance of notes payable, related parties		10,000
Proceeds from issuance of notes payable, related parties, convertible		20,000
Net cash provided by financing activities		80,000
Net decrease in cash and cash equivalents	1,912	(3,179)
Cash and cash equivalents, beginning of period	1,821	3,179
Cash and cash equivalents, end of period	3,733
Supplemental cash flow information:
Interest paid
Cash paid for income taxes
Schedule of Non-Cash Investing and Financing Activities:
Issuance of common stock as consideration for accounts payable		$ 29,000